ENVOY MEDICAL, INC.: cashflow_financing
| Value | {"amount": 21282000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | ENVOY MEDICAL, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:32:42.121857+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/db64a064-8b28-4850-b1c3-48fa1c9b7d66
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001013762-25-004299Retrieved: 2026-08-19T18:32:42.121857+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001840877/cashflow-financing/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/db64a064-8b28-4850-b1c3-48fa1c9b7d66
History
- supersedes {"amount": 21845000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} (evidence 0001213900-24-028894)